US Stocks
/
4D Molecular Therapeutics, Inc. Share Price

4D Molecular Therapeutics, Inc. Share Price

NASDAQ: FDMT | Small Cap
$12.59
+$0.04 (0.32%) Last updated on 08 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

4D Molecular Therapeutics, Inc. Stock Performance

Open
$12.56
Prev. Close
$12.55
Circuit Range
N/A
Day Range
$12.56 - $12.92
Year Range
$6.96 - $16.91
Volume
24,389
Average Traded
$12.70

4D Molecular Therapeutics, Inc. Share Price Today

As of 8 October 2026, 4D Molecular Therapeutics, Inc.'s share price is $12.59. The stock opened at $12.56, compared to its previous close of $12.55. During today's trading session, 4D Molecular Therapeutics, Inc.'s share price traded between $12.56 and $12.92, with an average price of $12.74. Over the past 52 weeks, the stock has recorded a high of $16.91 and a low of $6.96. In terms of performance, 4D Molecular Therapeutics, Inc.'s share price has risen by 41.78% over the last six months and is up 9.38% on a year-on-year basis.

4D Molecular Therapeutics, Inc. Share Price Chart

$12.56$12.92
L
Show Current Price
H

4D Molecular Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$729.34M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.24
Revenue (TTM)
$85.21B
Return On Equity (TTM)
-43.95%
Profit Margin
-164.43%
Debt to Equity
0.05
Quarterly Earnings Growth YoY
-28.23%

4D Molecular Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.09$85.09$3.05$3.78
Net Profit-$56.88$19.40-$68.76-$72.94
Net Profit Margin-63200.00%22.80%-2254.43%-1929.63%
Income ChangeN/A134.11%-454.43%-6.08%

4D Molecular Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$3.13$20.72$0.04$85.21
Net Profit-$107.49-$100.84-$160.87-$140.11
Net Profit Margin-3434.19%-486.68%-402175.00%-164.43%
Income ChangeN/A6.19%-59.53%12.90%

About 4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

4D Molecular Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$14.37
$12.59
-12.08%
Sep 2026
$14.04
$14.32
-3.83%
Aug 2026
$10.17
$14.89
+46.27%
Jul 2026
$13.12
$10.18
-23.43%
Jun 2026
$9.97
$13.29
+33.75%
May 2026
$9.01
$9.94
+11.94%
Apr 2026
$9.63
$8.88
-4.41%
Mar 2026
$9.34
$9.29
-3.93%
Feb 2026
$8.85
$9.67
+9.14%
Jan 2026
$7.59
$8.86
+18.45%
Dec 2025
$11.43
$7.48
-36.01%
Nov 2025
$11.56
$11.69
+1.56%

FDMT Share Price FAQs

What is 4D Molecular Therapeutics, Inc. share price today?

chevron-up
4D Molecular Therapeutics, Inc. share price today is $12.59 as on October 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of 4D Molecular Therapeutics, Inc. stock?

chevron-up
The 52 week high of 4D Molecular Therapeutics, Inc. stock is $16.91, while the 52 week low is $6.96 as of 8 Oct '26.

What is FDMT's market capitalisation today?

chevron-up
FDMT market capitalisation is $729.34M as of October 8, 2026, at 4:07 pm IST.

What is FDMT's net income for the last quarter?

chevron-up
FDMT's net income for the last quarter is -72.94B USD.

What is the 5 year returns of FDMT?

chevron-up
The 5 year returns of FDMT is -47.61% as on 8 Oct '26.

What is the high & low stock price of FDMT today?

chevron-up
FDMT stock price hit a high of $12.92 and low of $12.56 as of 8 Oct '26.

Can I buy FDMT shares in India?

chevron-up
Yes. You can buy FDMT in India by opening an international trading account.